Program
Program
Please find preliminary program below. This will be updated continually.
Click here for printed Program Book
Click here for digital Abstract Book
Monday, 9 September
The NSHG-PM workshop begins Monday 9th.
BN4 WP3 (pre-conference meeting): "How to present metadata from omics-technologies in a national data portal" (10:00-17:00).
Tuesday, 10 September
09:00
Registration opens
10:00 - 12:00
Parallel Workshops
Directions for NSHG-PM Workshop at NTNU, Campus Øya (Building: 1902, Room: 02S21)
Note: This 1-day workshop will begin midday on Monday, 9 September, and finish on the morning of Tuesday 10 September. It will include a networking dinner. Click for detailed program.
Conceptual introductions, higher level framing, and hands-on practicums covering three use cases: PGS, CNV, and register analysis. The exercises will be conducted in R and introduce advanced concepts in specific areas of genomics and AI/data science. The target audience is post-graduate trainees with a specific interest in the use cases or general interest in becoming more familiar with applied AI/data science.
Faculty: Clara Albiñana, Aarhus University, Denmark; Andrés Ingason, Institute of Biological Psychiatry, Denmark; Simone Montalbano, Institute of Biological Psychiatry, Denmark; Markus Perola, Finnish Institute of Health and Welfare, Finland; Andrew Schork, Institute of Biological Psychiatry, Denmark, Emil Pedersen, Aarhus University, Denmark
Conference Venue, Room: Vega
Note: This workshop begins at 10:30am
Navigating the UKB plasma proteomics data to explore the variability of proteins, learn about disease risk scores and proteogenomic associations.
Customer speaker, Christopher Foley, will present a breakthrough study using UK Biobank data, where machine learning was used to identify protein signatures linked to disease formation, enabling accurate prediction of disease risk up to 10 years before diagnosis. This cutting-edge research provides new insights into early detection and prevention, paving the way for proactive healthcare solutions.
Learning outcomes:
- An overview of how you can work alongside UKB-PPP data
- Examples of enriching your understanding of genomic data with the identification of pQTLs, PRS and normal ranges
Conference venue: Cosmos 3A
Implementing environmentally friendly biobanking practices can significantly reduce the carbon footprint of the biobanks and contribute to their long-term environmental sustainability. Through this workshop, we will explore Environmental impact of biobanking, Sustainable practices in biobanking, energy-efficient equipment to name a few.
Introduction to Green Biobanking
Introduction to green biobanking principles and benefits, current challenges
Saba Abdulghani, BBMRI-ERIC
Green Biobanking Practices
Nordic Biobanks perspective:
- Energy Recycling at HUNT Biobank
Vegard Marschhäuser, NTNU - Title TBD
Sumangala Battacharya, Aarhus University Hospital
Industry perspective
- Next-Generation Automated Storage Solutions for Greener Biobanking
Presenter TBD, HAMILTON - Sustainable Labware Solutions for Automated Sample Storage
Tobias Haessner, LVL technologies
Discussions
Conference venue: Cosmos 3B
There is no health research without research participants. Engaged participants not only provide biological samples and health data but also contribute to increase the quality and impact of the research. This workshop is to present and discuss innovative recruitment and engagement strategies to support health research in population studies and clinical research. Experiences from Nordic research groups, pros and cons of strategies, and practical aspects of recruitment and engagement, e.g., resource and time requirements, will be discussed.
11:00-13:00
Exhibition
12:00-13:00
Lunch (for workshop participants only)
Registration
13:00-13:20
Conference Opening: Welcome
Kristian Hveem, NTNU, Norway and Ole Andreassen, University of Oslo
13:20-15:10
Biobanks, Research, Innovation and Precision Medicine as a foundation of future health
Chair: Åsa Johansson, Uppsala University, Sweden
- Innovation: Molecular tools for more markers in more samples
Ulf Landegren, Uppsala University, Sweden (20 min.) - Research: Gut microbiome and drug interactions: The value of population-based biobanks
Elin Org, University of Tartu, Estonia (20 min.) - Biobanks: Opportunistic screening of genetic cancer risk variants from biobank samples
Minja Perhsson, Helsinki University Hospital, Finland (20 min.) - Precision Medicine: Rare genotype: from research to action
Patrick Sulem, deCODE Genetics, Iceland (20 min.)
Selected abstracts
Next pregnancy after pregnancy Loss – Copenhagen Pregnancy Loss (COPL) cohort
Laura Emilie Vexø, Copenhagen (15 min.)
Genomics and Proteomics of Heart Disease Risk Prediction in the Trøndelag Health Study
Brooke Wolford, NTNU, Norway (15 min.)
15:10-15:30
Exhibition and coffee break
15:30-17:00
Parallel Sessions
Chair: Christina Jern, Gothenburg University, Sweden
- Cognitive impairment in a prospective population-based study
Geir Selbæk, University of Oslo, Norway (20 min.) - AI and imaging of neurodegenerative diseases
Anders Dale, University College of San Diego, USA, and University of Oslo, Norway - Rare variants in psychiatric disorders
Thorgeir Thorgeirsson, deCODE genetics, Iceland (20 min.)
Abstract-selected talks
Development of a Convolutional Neural Network for Automated Copy Number Variants Validation and its Application in the UKB
Simone Monalbano, University of Copenhagen, Denmark (15 min.)
From Estonian biobank to practice: undiagnosed adult NDD-CNV carriers present complex health effects and express contentment to learn about their genetic finding
Marili Palover, University of Tartu, Estonia (15 min.)
Chair: Andreas Scheutz, Biobank Sweden
- Researcher perspective
Jon Snædal, Landspitale University Hospital, Iceland (20 min.) - Legal aspects
Katarina Trygg and Gustav Berg, Biobank Sweden (20 min.) - EHDS and international data sharing
Tom Southerington, Finnish biobank cooperative, Finland (20 min.)
Panel discussion: Jon Snædal, Katarina Trygg, Gustav Berg, Tom Southerington, Bart Wilkowski and Hilde Langseth (30 min.)
17:30-18:30
Welcome reception at Clarion Hotel and Congress (conference venue)
(Included in conference fee)
19:00
Social event: Rockheim - Norway's National Museum of Popular Music
(Separate fee, see registration portal)
Wednesday, 11 September
07:30
Registration opens
08:00-08:30
Industry Symposium: Biobanking and predictive genomics
Christine Regnell, Thermo Fisher
08:30-10:30
Health Data and Life Science in the Nordics– Research priorities, perspectives, and the role of AI
Chairs: Kristian Hveem, NTNU, Norway and Elisabeth Norén, Biobank Sweden, Sweden
- Data-Driven Life Science program and involvement of AI
Olli Kallioniemi, Karolinska Institutet, Sweden (20 min.) - Proteomics and Applications in Clinical Development
Hannes Helgasson, deCODE genetics, Iceland (20 min.) - Data – on health and beyond
Camilla Stoltenberg, NORCE, Norway, (20 min.) - Large population-wide studies: FinnGen and FinRegistry
Markus Perola, Finnish Institute for Health and Welfare, Finland (20 min.) - Visions for building a population-wide genomic dataset in Denmark
Mette Nyegaard, Statens Serum Institut, Denmark (20 min.)
Panel discussion
10:30-11:00
Exhibition and coffee break
11:00-12:00/12:10
Parallel Sessions
Chair: Siri Håberg, Norwegian Institute of Public Health and University of Oslo, Norway
Moving towards newborn sequencing
Asbjørg Stray-Pedersen, Oslo University Hospital, Norway (20 min)
Genetic differences between neonates and adults in well-known metabolites: The case of bilirubin
Pol Solè-Navais, Gothenburg University, Sweden (20 min.)
Selected Abstracts
GLP-1 receptor agonist treatment in early pregnancy and risk of pregnancy complications - A nationwide cohort study
Kathrine Hviid, Hvidovre Hospital, Denmark (15 min.)
Evaluating the Predictive Ability of Polygenic Risk Scores for Intrahepatic Cholestasis of Pregnancy in the Estonian Biobank
Fanny-Dhelia Pajuste, University of Tartu (15 min.)
Chair: Satu Koskela, FRC Blood Service Biobank, Finland
Fingenious- Your gateway to Finnish Biobanks and Biomedical research
Johanna Mäkelä, Finnish Biobank Cooperative - FINBB, Finland (20 min.)
Project FOREVER: Unlocking Big Data Potential Through Public-Private Partnerships
Miriam Kolko, University of Copenhagen and Copenhagen University Hospital, Denmark (20 min.)
The HUNT One Health study, a metagenomic sample and data repository for One Health-studies
Øivind Øines, Norwegian Veterinary Institute, Norway (20 min.)
12:00-13:00
Lunch
12:00-14:00
Exhibition and poster session
13:00-14:00
Ethics café: Trust in health research
Chair: Isabelle Budin Ljøsne, Norwegian Institute of Public Health, Norway
- Eskil Degsell, Vice Chairman of the Swedish Brain Tumor Association, Sweden (user representative)
- Karoliina Snell, University of Helsinki, Finland
14:00-15:15
Parallel Sessions
Chair: Marc Vaudel, University of Bergen, Norway
- Genetic timing of puberty
Ken K. Ong, University of Cambridge (20 min.) - Genetics of childhood growth
Stefan Johansson University of Bergen, Norway (20 min.) - Genetics of obesity
Andrea B. Jónsdóttir, deCODE genetics, Iceland (20 min.)
Selected Abstract
The Interplay Between Birth Weight and Obesity in Determining Childhood and Adolescent Cardiometabolic Risk
Sara Elisabeth Stinson, Denmark (15 min.)
Chair: Linda Paavilainen, Biobank Sweden, Sweden
- High quality cancer research from Janus Serum Bank samples stored for up to 50 years
Hilde Langseth, Cancer Registry of Norway, Norway - Healthcare integrated biobanking
Elin Stenfeldt, Biobank Sweden
Selected abstract
Comprehensive cancer-oriented biobanking for post-zygotic genetic variation in cancer predisposition
Natalia Helena Filipowitz. Medical University of Gdańsk, Poland
MicroRNA as biomarkers in early detection and personalized treatment in ovarian cancer: Development of a personalized prevention consortium
Reneé Turzanski Fortner, Cancer Registry of Norway
15:15-15:45
Exhibition and coffee break
15:45-17:00
Parallel Sessions
Chair: Bjørn Olav Åsvold, NTNU, Norway
- Oral species in the gut – association with atherosclerotic disease in large populations
Tove Fall, Uppsala University, Sweden (20 min.) - Genetic variants with non-additive, epistatic, or distributional effects; analysis of blood lipids and coronary artery disease, Iceland
Audunn S. Snæbjarnarson, deCODE genetics, Iceland (20 min.)
Selected Abstracts
Plasma Brain-Derived Tau is highly correlated to stroke infarct volume and improves outcome prediction in acute ischemic stroke
Tara M Stanne, University of Gothenburg, Sweden (15. min)
Genetic liability to sedentary behaviour increases the risk of sedentariness and cardiovascular disease incidence: Evidence from the FinnGen cohort with 293,250 individuals
Laura Joensuu, University of Jyväskylä, Finland (15 min.)
Chair: Auður Ýr Þorláksdóttir, Landspitali University Hospital, Iceland
- Hospital-integrated high-quality biobanking supporting biomedical research
Lila Kallio, Auria Biobank, Finland (20 min.) - Collaborate implementation of ISO 20387 by friendly crossaudits
Malin Åsblom and Karolin Bergenstråhle, Biobank Sweden and Uppsala Biobank, Sweden (20 min.)
Selected abstracts
Time-series assessment of 15 serum biochemical analytes to explore storage time impact up to 9 years at -25 °C
Steffan Daniel Bos, Norwegian Institute of Public Health, Norway (15 min)
Accessing Swedish biobank cohorts: Practicalities and some legal aspects
Ulrika Morris, Umeå, Sweden (15 min.)
18:00-19:00
Social event: Organ Concert at Nidaros Cathedral
(Included in conference fee, sign up for transportation in registration portal)
![](/documents/1338783544/0/_NDR3087.jpg/53b10c05-ae2a-1ae1-6743-0e992bbb940d?t=1723713793489)
19:30
Social event: Conference Dinner Reception
(Separate fee, see registration portal)
Thursday, 12 September
07:30 Registration opens
08:00-08:30
Industry Symposium: Your Guide to a Greener and Safer Biobank
Claudia Donovan, Nerliens Meszansky
08:30-09:40
Latest in Biobanking and Precision Medicine (short overview)
Chair: Liv Paltiel, Oslo University Hospital and Biobank Norway, Norway
Denmark - Biobank: Anne-Marie Vangsted, PM: Mette Nyegaard
Estonia - Biobank: Maarja Jõeloo, PM: Sander Pajusalu
Finland - Biobank: Johanna Mäkelä, PM: Markus Perola
Iceland - Biobank: Auður Ýr Þorláksdóttir, PM: Hanne Helgasson
Norway - Biobank: Kristian Hveem, PM: Åslaug Helland
Sweden - Biobank: Lena Thunell, PM: Åsa Johansson
09:40-10:30
Transformative use cases for future health - novel opportunities for biobanking and precision medicine in the Nordics
Introduction and presentation of selected use case
Ole Andreassen, University of Oslo (15 min.)
The way forward - Open discussion (30 min.)
Moderator: Ole Andreassen
10:30-11:00
Exhibition and coffee break
11:00-12:00
Parallel Sessions
Chair: Eivind Hovig, UiO, Norway
- Recent developments in Precision Cancer Medicine in Norway
Åslaug Helland, University of Oslo, Norway (20 min.) - Ten years of implemented genomic medicine in cancer. The Danish experience
Ulrik Lassen, Rigshospitalet København, Denmark (20 min.)
Abstract-Selected Talk
Identifying proteins that mediate the association between hormonal contraceptive use and breast cancer development: A two-stage observational and Mendelian Randomization study
Tayebeh Azimi, Uppsala, Sweden (15 min.)
Chair: Isabelle Budin Ljøsne, Norwegian Institute of Public Health, Norway
- Towards a more general consent for the use of patients’ biological material and health information for medical research - The patient perspective
Rebecca Bruu Carver, FHI, Norway (15 min.) - EPITOP Biobank: Innovative collection of residual clinical blood volumes from extremely preterm infants for biomarker research
Ulrika Sjøbom, Sweden (15 min.) - MoBa explorer: enabling the navigation of GWAS summary statistics from the Norwegian Mother, Father, and Child Cohort Study (MoBa)
Hanna Balaka, FHI, Norway (15 min.) - Returning genetic risk information from biobank to blood donors – hemochromatosis
Jonna Clancy, Finland (15 min.)
12:00-13:00
Lunch
12:00-13:00
Exhibition and coffee break
13:00-14:15
Parallel Sessions
- Assessing the susceptibility of celiac disease by polygenic risk scores: Analysis of a population-based cohort, the HUNT study
Mohammad Sayeef Alam, NTNU, Norway (15 min.) - Mapping the familial and genetic basis of eating disorders: A comprehensive national register study of Denmark and Sweden
Joeri Meijsen, University of Copenhagen, Denmark (15 min.) - Exploring genetic clustering of severity markers to identify groups with reduced heterogeneity in multiple sclerosis
Pernilla Stridh, Karolinska Institutet, Sweden (15 min.) - Leveraging long-read sequencing data to solve complex genomic regions
Maarja Jõeloo, Estonia (15 min.) - Lethal mutations in the germline
Hákon Jónsson, deCODE (15 min.)
Chair: Anne-Marie Vangsted, SSI, Denmark
Protocols and ambitions for re-use of biodata in the HUNT Study
Therese Haugdahl Nøst, NTNU, Norway (20 min.)
Vision & directions for data recollection and sharing at the Danish National Biobank
Bart Wilkowski, Statens Serum Institut, Denmark (20 min.)
Selected abstracts
Customized genotype-based selection of fresh living cells for biomedical research from blood donor biobank
Satu Koskela, Finland (15 min.)
From multi-omics to better health – Managing the biological data resource in the Norwegian Mother, Father and Child Cohort Study (MoBa)
Even Birkeland, Norway (15 min.)
14:15-14:30
Coffee break
14:30-15:00
Global Long COVID Genetics Host Initiative
Vilma Lammi, University of Helsinki, Finland (15 min.)
Host genome-wide association study of the Swedish gut microbiome
Koen F Dekkers, Uppsala, Sweden (15 min.)
15:00-15:20
Chair: Kristian Hveem, NTNU, Norway
Advancing Biobanking in Europe to Foster Genomic Medicine - a 10-year strategy and Nordic National Nodes Involvement
Jens Habermann, Director General BBMRI-ERIC (20 min.)
15:20-15:30
Poster Awards
15:30-15:40
Closing Remarks